Tucson, U.S. and Salzburg, Austria – 3dbiosurfaces and STRATEC Consumables GmbH, a wholly owned subsidiary of STRATEC, announced today the release of the first commercially available microarray substrate based on 3dbiosurfaces patented and patent-pending technologies. The 3D NS-NC slide provides enormous benefits for both DNA/RNA and protein microarrays at attractive prices. The slide offers greatly […]
Collaboration to Focus on Computational Chemistry and Molecular Recognition in the Human Body NEW YORK, NY and SHANGHAI, CHINA (November 7, 2017) – Schrödinger, Inc., a world-leading provider of advanced molecular simulations and drug discovery software solutions, and ShanghaiTech University in China have reached an agreement to develop a strategic partnership and establish the Shanghai […]
Project to improve biomedical data efficiency and reliability NEW YORK Elsevier and Seven Bridges Genomics announced today that The National Institutes of Health(NIH) has awarded them a grant for the development of a comprehensive, open-source data analysis ecosystem as part of its Data Commons Pilot Phase. The project is designed to improve data efficiency and reliability for the over 70,000 […]
Genovis continues to expand in Asia and has signed a distribution agreement with Shanghai Titan Scientific Ltd. A growing number of companies in China are focusing on biopharmaceuticals, at the same time that global pharmaceutical companies are locating their process development and production in the area. Consequently there is a strong need for Genovis’ products […]
Waltham, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands at Repligen’s facilities in Waltham, MA and Lund, Sweden. Repligen is the main strategic supplier of Protein A ligands to Purolite, an emerging player in the Protein A […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early […]
Collaboration aimed at developing novel “Nephron-on-a-Chip” device to test drug candidates in human kidney: NEPLEX (“NEPHRON-ON-A-CHIP WITH CELLULAR AND EXTRACELLULAR MATRIX COMPLEXITY”) Major step forward to the next generation kidney platform Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell […]
As of October 2017 Micronit, Axxicon and Helvoet are collaborating in offering a market leading development and manufacturing package to support the growing global demand for high volume polymer microfluidic products. The strong market growth is driven by the new fast diagnostic systems being developed and entering the health care market. At the same time […]
The Institute of Genetics and Molecular and Cellular Biology and Leica Microsystems marked 20 years of collaboration with a day of presentations and scientific talks highlighting the successful projects emerging from the partnership Strasbourg, November 3rd. The longstanding alliance between one of the largest research institutes in France and the pioneering microscopy company was […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early discovery […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
